Differential diagnosis of substance-induced psychosis and schizophrenia in patients with substance use disorders

Schizophrenia Bulletin

Volumn 23, Issue 2, 1997, Pages 187-193

  Rosenthal, Richard N ^a,b   Miner, Christian R ^a,b  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHADONE;

ADULT; ARTICLE; CLINICAL FEATURE; COMORBIDITY; DELUSION; DIFFERENTIAL DIAGNOSIS; DRUG DETOXIFICATION; DRUG INDUCED DISEASE; FEMALE; HALLUCINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; SUBSTANCE ABUSE; SUICIDE;

EID: 0030922989     PISSN: 05867614     EISSN: None     Source Type: Journal    
DOI: 10.1093/schbul/23.2.187     Document Type: Article

References (42)

1. American Psychiatric Association. DSM-III-R: Diagnostic and Statistical Manual of Mental Disorders. 3rd ed., revised. Washington, DC: The Association, 1987.
2. American Psychiatric Association. DSM-IV: Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: The Association, 1994.
3. Becker, H.C., and Hale, R.L. Repeated episodes of ethanol withdrawal potentiate the severity of subsequent withdrawal seizures: An animal model of alcohol withdrawal "kindling." Alcoholism, Clinical and Experimental Research, 17:94-98, 1993.
4. Brady, K.T.; Killeen, T.L.; and Jarrell, P. Depression in alcoholic schizophrenic patients. American Journal of Psychiatry, 150:1255-1256, 1993.
5. Brady, K.T.; Lydiard, R.B.; Malcolm, R.; and Ballenger, J.C. Cocaine-induced psychosis. Journal of Clinical Psychiatry, 52:509-512, 1991.
6. Breier, A.; Schreiber, J.L.; Dyer, J.; and Pickar, D. National Institute of Mental Health longitudinal study of chronic schizophrenia: Prognosis and predictors of outcome. Archives of General Psychiatry, 48:239-246, 1991.
7. Brown, M.E.; Anton, R.F.; Malcolm, R.; and Ballenger, J.C. Alcohol detoxification and withdrawal seizures: Clinical support for a kindling hypothesis. Biological Psychiatry, 23:507-514, 1988.
8. Brown, S.A., and Schuckit, M.A. Changes in depression among abstinent alcoholics. Journal of Studies on Alcohol, 49:412-417, 1988.
9. Bunt, G.; Galanter, M.; Lifshutz, H.; and Castaneda, R. Cocaine/"crack" dependence among psychiatric inpatients. American Journal of Psychiatry, 147:1542-1546, 1990.
10. Carone, B.J.; Harrow, M.; and Westermeyer, J.F. Post-hospital course and outcome in schizophrenia. Archives of General Psychiatry, 48:247-253, 1991.
11. Casteneda, R.; Galanter, M.; Lifshutz, H.; and Franco, H. Effect of drugs of abuse on psychiatric symptoms among hospitalized schizophrenics. American Journal of Drug and Alcohol Abuse, 17:313-320, 1991.
12. Cleghorn, J.M.; Kaplan, R.D.; Szechtman, B.; Szechtman, H.; Brown, G.M.; and Franco, S. Substance abuse in schizophrenia: Effects on symptoms but not on cognitive functions. Journal of Clinical Psychiatry, 52:26-30, 1991.
13. Cornelius, J.R.; Mezzich, J.; Fabrega, H.; Cornelius, M.D.; Myers, J.; and Ulrich, R.F. Characterizing organic hallucinosis. Comprehensive Psychiatry, 32:338-344, 1991.
14. Cornelius, J.R.; Salloum, I.M.; Mezzich, J.; Cornelius, M.D.; Fabrega, H.; Ehler, J.G.; Ulrich, R.F.; Thase, M.E.; and Mann, J.J. Disproportionate suicidality in patients with comorbid major depression and alcoholism. American Journal of Psychiatry, 152:358-364, 1995.
15. Dassori, A.M.; Mezzich, J.E.; and Keshavan, M. Suicidal indicators in schizophrenia. Acta Psychiatrica Scandinavica, 81:409-413, 1990.
16. Dorus, W.; Kennedy, J.; Gibbons, R.D.; and Ravi, S.D. Symptoms and diagnosis of depression in alcoholics. Alcoholism: Clinical and Experimental Research, 11:150-154, 1987.
17. Fenton, W.S., and McGlashan, T.H. Testing systems for assessment of negative symptoms in schizophrenia. Archives of General Psychiatry, 49:179-184, 1992.
18. Fernandez-Pol, B.; Bluestone, H.; and Mizruchi, M.S. Inner-city substance abuse patterns: A study of psychiatric inpatients. American Journal of Drug and Alcohol Abuse, 14:41-50, 1988.
19. Flaster, C.J. "Delusional Symptomatology in a Dual-Diagnosis Population." Unpublished master's thesis, Department of Psychology, New York University, 1990.
20. Kane, J.M., and Selzer, J. Considerations on "organic" exclusion criteria for schizophrenia. Schizophrenia Bulletin, 17(1):69-73, 1991.
21. Kulick, A.R., and Ahmed, I. Substance-induced organic mental disorders: A clinical and conceptual approach. General Hospital Psychiatry, 8:168-172, 1986.
22. Levy, D.L.; Smith, M.; Robertson, D.; Jody, D.; Lerner, G.; Alvir, J.; Geisler, S.H.; Szymanski, S.R.; Gonzalez, A.; Mayerhoff, D.I.; Lieberman, J.A.; and Mendell, N.R. Methylphenidate increases thought disorder in recent onset schizophrenics, but not in normal controls. Biological Psychiatry, 34:507-514, 1993.
23. Mendoza, R., and Miller, B.L. Neuropsychiatric disorders associated with cocaine use. Hospital and Community Psychiatry, 43:677-680, 1992.
24. Mitchell, J., and Vierkant, A.D. Delusions and hallucinations of cocaine abusers and paranoid schizophrenics: A comparative study. Journal of Psychology, 125:301-310, 1991.
25. Olivera, A.A.; Kiefer, M.W.; and Manley, N.K. Tardive dyskinesia in psychiatric patients with substance abuse disorders. American Journal of Drug and Alcohol Abuse, 16:57-66, 1990.
26. Pinsker, H. The allegedly suicidal patient in the general hospital. General Hospital Psychiatry, 3:277-282, 1981.
27. Regier, D.A.; Farmer, M.E.; Rae, D.S.; Locke, B.Z.; Keith, S.J.; and Judd, L.L. Co-morbidity of mental disorders with alcohol and other drug abuse: Results from the Epidemiological Catchment Area (ECA) Study. Journal of the American Medical Association, 264:2511-2518, 1990.
28. Rosenthal, R.N.; Hellerstein, D.J.; and Miner, C.R. A model of integrated services for outpatient treatment of patients with comorbid schizophrenia and addictive disorders. American Journal on Addictions, 1:339-342, 1992a.
29. Rosenthal, R.N.; Hellerstein, D.J.; and Miner, C.R. Integrated services for treatment of schizophrenic substance abusers: Demographics, symptoms and substance abuse patterns. Psychiatric Quarterly, 63:3-26, 1992b.
30. Rosenthal, R.N.; Hellerstein, D.J.; and Miner, C.R. Positive and negative syndrome typology in schizophrenic patients with psychoactive substance use disorders. Comprehensive Psychiatry, 35:91-98, 1994.
31. SAS Users Guide: Statistics. 6th ed. Cary, NC: SAS Institute, 1992.
32. Satel, S.L.; Southwick, S.M.; and Gawin, F.H. Clinical features of cocaine-induced paranoia. American Journal of Psychiatry, 148:495-498, 1991.
33. Shaner, A.; Khalsa, M.E.; Roberts, L.; Wilkins, J.; Anglin, D.; and Hsieh, S.C. Unrecognized cocaine use among schizophrenic patients. American Journal of Psychiatry, 150:758-762, 1993.
34. Surawicz, F.G. Alcoholic hallucinosis: A missed diagnosis. Canadian Journal of Psychiatry, 25:57-63, 1980.
35. SYSTAT: Statistics. Version 5.2.1 edition Evanston, IL: SYSTAT, Inc., 1992.
36. Szuster, R.R.; Schanbacher, B.L.; McCann, S.C.; and McConnell, A. Underdiagnosis of psychoactive-substance-induced organic mental disorders in emergency psychiatry. American Journal of Drug and Alcohol Abuse, 16:319-327, 1990.
37. Tsuang, M.S.; Simpson, J.C.; and Kronfol, Z. Subtypes of drug abuse with psychosis: Demographic characteristics, clinical features, and family history. Archives of General Psychiatry, 39:141-147, 1982.
38. Weiss, R.D., and Collins, D.A. Substance abuse and psychiatric illness: The dually diagnosed patient. American Journal on Addictions, 1:93-99, 1992.
39. Weiss, R.D.; Griffin, M.L.; and Mirin, S.M. Diagnosing major depression in cocaine abusers: The use of depression rating scales. Psychiatry Research, 28:335-343, 1989.
40. Widiger, T.; Frances, A.; and Pincus, H., eds. DSM-IV Sourcebook. Washington, DC: American Psychiatric Press, 1993.
41. Woody, G.; Schuckit, M.A.; Weinreib, R.; and Yu, E. A review of the substance use disorders section of the DSM-IV. In: Miller, N., ed. Recent Advances in Addictive Disorders. Philadelphia, PA: W.B. Saunders & Company, 1993. pp. 21-32.
42. Ziedonis, D.M.; Kosten, T.R.; and Glazer, W.M. "The Impact of Drug Abuse on Psychotic Outpatients." Presented at the 145th Annual Meeting of the American Psychiatric Association, Washington, DC, May 1992.